Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

[ad_1] Updated Nov. 20, 2023 3:16 pm ET Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and…